Key Finding
Acupuncture stimulation activates mechanosensitive Ptgs2+ telocytes in fascia, which trigger M2 macrophage polarization through the Il6-Il6st-Stat3 pathway, establishing a cellular "force-immune axis" that mediates anti-inflammatory effects.
Scientists have made an important discovery about how acupuncture works at the cellular level to reduce inflammation in the body. Researchers studied a special layer of connective tissue called fascia that runs along the midline of the abdomen, which contains multiple acupuncture points. Using advanced imaging techniques, they identified specialized cells called telocytes within this tissue, particularly a subtype called Ptgs2+ CPTCs.
The study used rats with dysentery, an inflammatory intestinal condition, and applied acupuncture at specific points along the abdominal fascia. The researchers found that acupuncture stimulation caused the Ptgs2+ CPTC cells to increase significantly in number and become more active. These cells appear to act as a bridge between mechanical force (the needle insertion) and the immune system's response.
Most significantly, the activated Ptgs2+ CPTC cells triggered a chain reaction that converted immune cells called macrophages into their anti-inflammatory form (M2 macrophages). This conversion happened through a specific biological pathway involving proteins called Il6, Il6st, and Stat3. The result was a reduction in inflammation.
This research is groundbreaking because it provides concrete cellular evidence for how acupuncture's mechanical stimulation translates into therapeutic anti-inflammatory effects. For patients with immune-related inflammatory conditions, this helps explain why acupuncture may be effective and validates its use as a complementary therapy. The findings suggest acupuncture may be particularly beneficial for conditions involving chronic inflammation, including digestive disorders, arthritis, and other inflammatory diseases.
If you're considering acupuncture for an inflammatory condition, seek treatment from a licensed acupuncturist with appropriate credentials in your jurisdiction.
This study employed single-cell sequencing and deep learning to characterize the cellular composition of abdominal midline fascia (AMF), identifying six subpopulations of Cd34+/Pdgfra+ telocytes (CPTCs). In a dysenteric rat model, acupuncture stimulation at AMF acupoints significantly increased the proportion of mechanosensitive Ptgs2+ CPTCs, which demonstrated enhanced intercellular adhesion across all CPTC subpopulations.
The mechanistic investigation revealed that Ptgs2+ CPTCs activate M2 macrophage polarization via the Il6-Il6st-Stat3 signaling pathway, producing anti-inflammatory effects. This represents the first identification of a "force-immune axis" whereby mechanical acupuncture stimulation is transduced through fascial telocytes to modulate immune responses.
Clinical implications: This research provides cellular-level evidence supporting acupuncture's anti-inflammatory mechanisms, particularly for immune-mediated conditions. The findings suggest that acupoint selection along fascial planes rich in mechanosensitive telocytes may optimize therapeutic outcomes. Practitioners should consider fascia-targeted needling techniques when treating inflammatory and immune-related disorders, with particular attention to the mechanotransductive properties of connective tissue at classical acupoint locations.
Browse our directory of verified licensed practitioners near you.
Find a practitioner โ๐ Dysregulation of m7G RNA modifications, catalyzed by three major methyltransferase complexes in the CNS, is associated with the pathogenesis of multiple neurological diseases including Alzheimer's disease, ALS, epilepsy, glioblastoma, and ischemic stroke.
๐ Acupuncture significantly reduced thyroid antibodies (TPOAb and TGAb) and TSH levels in Hashimoto thyroiditis patients, though methodological limitations prevent reliable clinical recommendations pending higher-quality research.
๐ Liproxstatin-1 significantly reduced cerebral ischemia-reperfusion injury in rats by inhibiting ferroptosis through increasing neuroprotective factors GPX4 and FTH1 while decreasing ferroptosis markers NOX1, ACSL4, COX2, and TFR1.